TNF and myeloproliferative neoplasm: MPN driver mutations lead to the activation of a pro-inflammatory signaling cascade, which includes tumor necrosis factor (TNF)/nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB) pathway in mutated HSCs and their progeny [47].